Antibodies to chemokine β-15

Details Antibodies to chemokine β-15 Antibodies to chemokine β-15

2006-10-02

2010-11-09

Kemmerer, Elizabeth C. (Department: 1646)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C435S007210, C435S449000, C435S325000, C435S326000, C435S331000, C435S336000, C530S350000, C530S387100, C530S387300, C530S387900, C530S388100, C530S388230, C530S388240, C530S389100, C530S389200

Reexamination Certificate

active

07829293

ABSTRACT:
The present invention concerns a member of the human chemokine CC protein family. In particular, isolated nucleic acid molecules are provided encoding the chemokine β-15 protein. Chemokine β-15 polypeptides are also provided. The invention further concerns diagnostic methods for detecting thymus disorders and therapeutic methods for modulating bone marrow cell proliferation and differentiation.

REFERENCES:
patent: 5278287 (1994-01-01), Rollins et al.
patent: 5306709 (1994-04-01), Gewirtz
patent: 5504003 (1996-04-01), Li et al.
patent: 5556767 (1996-09-01), Rosen et al.
patent: 5605817 (1997-02-01), Coleman et al.
patent: 6723520 (2004-04-01), Wang et al.
patent: WO 90/02762 (1990-03-01), None
patent: WO 92/00326 (1992-01-01), None
patent: WO 92/00327 (1992-01-01), None
patent: WO 92/05198 (1992-04-01), None
patent: WO 92/13553 (1992-08-01), None
patent: WO 93/09799 (1993-05-01), None
patent: WO 95/17092 (1995-06-01), None
patent: WO 96/16979 (1996-06-01), None
patent: WO 96/24668 (1996-08-01), None
patent: WO 98/01557 (1998-01-01), None
patent: WO 98/44117 (1998-10-01), None
Bischoff, S.C. et al., “Monocyte Chemotactic Protein 1 Is a Potent Activator of Human Basophils,”J. Exp. Med. 175:1271-1275 (1992).
Bischoff, S.C. et al., “RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors,”Eur. J. Immunol. 23:761-767 (1993).
Chang, M.S. et al., “Cloning and Characterization of the Human Neutrophil-activating Peptide (ENA-78) Gene,”J. Biol. Chem. 269(41):25277-25282 (1994).
Damme, J. et al., “Structural and Functional Identification of Two Human, Tumor-derived Monocyte Chemotactic Proteins (MCP-2 and MCP-3) Belonging to the Chemokine Family,”J. Exp. Med. 176:59-65 (1992).
Fuentes, M.E. et al., “Controlled Recruitment of Mono-cytes and Macrophages to Specific Organs Through Transgenic Expression of Monocyte Chemoattractant Protein-1,”J. Immunol. 155:5769-5776 (Dec. 1995).
Graham, G.J. and Pragnell, I.B., “SCI/MIP-lα: A Potent Stem Cell Inhibitor with Potential Roles in Development,”Devel. Biol. 151:377-381 (1992).
Hare, T. et al., “Molecular Cloning and Functional Characterization of a Novel Member of the C-C Chemokine Family,”J. Immunol. 155:5352-5358 (Dec. 1995).
Howard, O.M.Z. et al., “Chemokines: progress toward identifying molecular targets for therapeutic agents,”TIBTECH14:46-51 (Feb. 1996).
Jiang, Y. et al., “Monocyte Chemoattractant Protein-1 Regulates Adhesion Molecule Expression and Cytokine Production in Human Monocytes,”J. Immunol. 148(8):2423-2428 (1992).
Johnson II, M.C. et al., “Cloning of two rabbitGROhomologues and their expression in alveolar macrophages,”Gene151:337-338 (1994).
Jose, P.J. et al., “Eotaxin: A Potent Eosinophil Chemoattractant Cytokine Detected in a Guinea Pig Model of Allergic Airways Inflammation,”J. Exp. Med. 179:881-887 (1994).
Kurdowska, A. et al., “Biological and Kinetic Characterization of Recombinant Human Macrophage Inflammatory Peptides 2 Alpha and Beta and Comparison with the Neutrophil Activating Peptide 2 and Interleukin 8,”Cytokine6(2):124-134 (1994).
Lukacs, N.W. et al., “The Role of Macrophage Inflammatory Protein lα inSchistosoma mansoniEgg-induced Granulomatous Inflammation,”J. Exp. Med. 177:1551-1559 (1993).
Luo, Y. et al., “Biologic Activities of the Murine β-Chemokine TCA3,”J. Immunol. 153:4616-4624 (1994).
McColl, S.R. et al., “Uncoupling of Early Signal Transduction Events from Effector Function in Human Peripheral Blood Neutrophils in Response to Recombinant Macrophage Inflammatory Proteins-1α and -1β,”J. Immunol. 150:4550-4560 (1993).
Miller, M.D. and Krangel, M.S., “Biology and Biochemistry of the Chemokines: A Family of Chemotactic and Inflammatory Cytokines,”Crit. Rev. Immunol. 12(1,2):17-46 (1992).
Minty, A. et al., “Molecular cloning of the MCP-3 chemokine gene and regulation of its expression,”Eur. Cytokine Netw. 4(2):99-110 (1993).
Opdenakker, G. et al., “Human monocyte chemotactic protein-3 (MCP-3): molecular cloning of the cDNA and comparison with other chemokines,”Biochem. Biophys. Res. Comm. 191(2):535-542 (1993).
Poltorak, A. et al., “Molecular Cloning of MIP-1γ, A New Member of the Chemokine Family, Through Differential Screening Based on Extinction of Macrophage-Specific Genes,”Clin. Res. 42(2):306A (1994).
Power, C.A. et al., “Cloning of a full-length cDNA encoding the neutrophil-activating peptide ENA-78 from human platelets,”Gene151:333-334 (1994).
Proost, P. et al., “Human and Bovine Granulocyte Chemotactic Protein-2: Complete Amino Acid Sequence and Functional Characterization as Chemokines,”Biochemistry32:10170-10177 (1993).
Proost, P. et al., “Purification, Sequence Analysis, and Biological Characterization of a Second Bovine Monocyte Chemotactic Protein-1 (Bo MCP-1B),”Biochemistry33:13406-13412 (1994).
Proudfoot, A.E.I. et al., “Extension of Recombinant Human RANTES by the Retention of the Initiating Methionine Produces a Potent Antagonist,”J. Biol. Chem. 271(5):2599-2603 (Feb. 1996).
Schulz-Knappe, P. et al., “HCC-1, a Novel Chemokine from Human Plasma,”J. Exp. Med. 183:295-299 (Jan. 1996).
Wells, T.N.C. et al., “Selectivity and antagonism of chemokine receptors,”J. Leukoc. Biol. 59:53-60 (Jan. 1996).
Yoshida, T. et al., “Molecular cloning of a novel C or γ type chemokine, SCM-1,”FEBS Lett. 360:155-159 (Feb. 1995).
Youn, B.S. et al., “A novel chemokine, macrophage inflammatory protein-related protein-2, inhibits colony formation of bone marrow myeloid progenitors,” J. Immunol. 155(5):2661-2667 (1995).
International Search Report for WO Application No. PCT/US95/09058 (Mailing Date: Oct. 19, 1995).
Adams, M.D. et al., “Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence,”Nature377:3-174 (1995).
Hillier, L. et al., Accession No. N73958 (Mar. 1996).
Kennedy, J. et al., “Molecular Cloning and Functional Charaterization of Human Lymphotactin,”J. Immunol. 155:203-209, American Association of Immunologists (1995).
Loster, A.D., and Leder, P., “IP-10, a —C-X-C- Chemokine, Elicits a Potent Thymus-dependent Antitumor Response In Vivo,”J. Exp. Med. 178:1057-1065, Rockefeller University Press (1993).
Meyer, A. et al., “Cloning and Characterization of a Novel Murine Macrophage Inflammatory Protein-1α Receptor, ”J. Bio. Chem. 271:14445-14451, American Society for Biochemistry and Molecular Biology, Inc. (1996).
Ngo et al., The Protein Foliding Problem and Teriary Structure Prediction. pp. 492-495. Birkhauser, Boston, (1994).
Robson, et al., Introduction to Proteins and Protein Engineering. Elsevier, Amsterdam, (1986).
Wells, Biochemistry, vol. 29, No. 37, pp. 8509-8517, (1990).
Bowie, et al., Science, vol. 247, pp. 1306-1310, (1990).

Affiliated with

Also associated with

Rating

Antibodies to chemokine β-15 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibodies to chemokine β-15, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to chemokine β-15 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4190230